4 Tips for Approaching Patients with Psoriasis
This article offers pearls that are often overlooked, but can make a big impact in the quality of care we provide to our patients with psoriasis. If all four are too difficult to include in your next clinic visit, focus on just one or two that you can you incorporate into your regular care of patients with psoriasis.
1. Psoriatic Arthritis
We all know that 30% of psoriasis patients develop psori …
This article offers pearls that are often overlooked, but can make a big impact in the quality of care we provide to our patients with psoriasis. If all four are too difficult to include in your next clinic visit, focus on just one or two that you can you incorporate into your regular care of patients with psoriasis.
1. Psoriatic Arthritis
We all know that 30% of psoriasis patients develop psori … Continue reading "4 Tips for Approaching Patients with Psoriasis"
With the American Academy of Dermatology Annual Meeting (often referred to as just "AAD") in Denver at the end of March, excitement is in the air! Without a doubt the Super Bowl of dermatology conferences, AAD can be an accelerating and even career-shaping experience, but the first time it can be equally overwhelming. Whether you are a medical student exploring dermatology or a first-year resident … 
The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investi … 
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs … 
Tacrolimus and Pimecrolimus are both calcineurin inhibitors FDA-approved for atopic dermatitis. However, their topical use offers steroid-sparing benefits for a wide variety of other inflammatory dermatologic conditions. Tacrolimus was discovered in 1984 from the soil bacterium Streptomyces tsukubaensis and was originally FDA approved in 1994 as a systemic immunosuppressant for organ transplanta …